Clinical experience of conversion from cyclosporine to tacrolimus prolonged-release in stabilized kidney transplant patients

Background and Aims: The CONCERTO study results showing the beneficial effects of conversion from cyclosporine to tacrolimus prolonged-release (tacrolimus PR) in stabilised patients after kidney transplantation, were first published in 2011. This communication describes our first experience of conve...

Full description

Bibliographic Details
Published in:	Biomedical Papers
Main Authors:	Karel Krejci, Josef Zadrazil, Eva Lackova, Zuzana Zilinska, Robert Roland, Ivana Dedinska
Format:	Article
Language:	English
Published:	Palacký University Olomouc, Faculty of Medicine and Dentistry 2016-09-01
Subjects:	tacrolimus prolonged-release cyclosporine immunosuppressive conversion kidney transplantation
Online Access:	https://biomed.papers.upol.cz/artkey/bio-201603-0011_Clinical_experience_of_conversion_from_cyclosporine_to_tacrolimus_prolonged-release_in_stabilized_kidney_transp.php

Similar Items

Evaluation of the Efficacy of Topical Tacrolimus and Intraperitoneal Cyclosporine as a Treatment Method for Acute Rejection In vivo Model of Skin Allotransplantation
by: Dilgam Mammadov, et al.
Published: (2025-01-01)

Comparison of Semen Analysis Parametes Changes after Priscription of Two Immunosuppresive Drugs, Tacrolimus and Cyclosporine in Men Undergoing Renal Transplantation
by: Ali Ramouz, et al.
Published: (2016-12-01)

Comparison of Semen Analysis Parametes Changes after Priscription of Two Immunosuppresive Drugs, Tacrolimus and Cyclosporine in Men Undergoing Renal Transplantation
by: Ali Ramouz, et al.
Published: (2017-02-01)

Efficacy and safety of prolonged-release versus immediate-release tacrolimus in de novo liver transplant recipients in South Korea: a randomized open-label phase 4 study (MAPLE)
by: Myoung Soo Kim, et al.
Published: (2019-06-01)

Comparison of the possible side effects of cyclosporine and tacrolimus on renal function in kidney transplant patients
by: Mohammed A. Abdulbari
Published: (2019-06-01)

The use of extended-release tacrolimus twice a day might be beneficial for selected kidney transplant recipients: a case report
by: Louise Füessl, et al.
Published: (2024-06-01)

A single‐center, open‐label, randomized cross‐over study to evaluate the pharmacokinetics and bioavailability of once‐daily prolonged‐release formulations of tacrolimus in de novo liver transplant recipients
by: Uta Herden, et al.
Published: (2021-12-01)

Use of tacrolimus to prevent acute kidney graft rejection in sensitized patients
by: O. N. Rzhevskaya, et al.
Published: (2018-08-01)

Clinical and safety outcomes of conversion original tacrolimus to generic tacrolimus in Turkish kidney transplant recipients
by: Emrah Günay
Published: (2020-09-01)

Effective Tacrolimus Treatment for Patients with Non-Severe Aplastic Anemia That is Refractory/Intolerant to Cyclosporine A: A Retrospective Study
by: Du Y, et al.
Published: (2020-12-01)

Clinical laboratory aspects of one-component immunosuppression during liver transplantation
by: M. Sh. Khubutia, et al.
Published: (2018-08-01)

Comparative Evaluation of Tacrolimus and Cyclosporine in Patients with Steroid-resistant Nephrotic Syndrome: A Systematic Review and Meta-analysis
by: Yalda Ravanshad, et al.
Published: (2019-09-01)

The safety of cyclosporine and tacrolimus in pediatric nephrotic syndrome patients: a disproportionate analysis based on the FAERS database
by: Yu Liu, et al.
Published: (2025-01-01)

Stability and Safety Traits of Novel Cyclosporine A and Tacrolimus Ophthalmic Galenic Formulations Involved in Vernal Keratoconjunctivitis Treatment by a High-Resolution Mass Spectrometry Approach
by: Daniele Giovanni Ghiglioni, et al.
Published: (2020-04-01)

Tacrolimus for the Treatment of Ulcerative Colitis
by: Katsuyoshi Matsuoka, et al.
Published: (2015-07-01)

Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study
by: Majda Sahman, et al.
Published: (2021-03-01)

Meltdose Tacrolimus Population Pharmacokinetics and Limited Sampling Strategy Evaluation in Elderly Kidney Transplant Recipients
by: Jasper Kamp, et al.
Published: (2023-12-01)

Adherence to, and patient convenience of, prolonged-release tacrolimus in stable kidney and liver transplant recipients after conversion from immediate-release tacrolimus in routine clinical practice in Switzerland
by: Marco Bonani, et al.
Published: (2021-02-01)

The Effect of Cyclosporine and Tacrolimus Systemic Therapy on Gingival Overgrowth in Renal Transplant Patients Aged Between 18-70 Years in Erbil City-Iraq
by: Aveen A. Jalal
Published: (2025-06-01)

Influence of different formulations of tacrolimus on dosage regimen and drug exposure within the first year after kidney transplantation
by: Stefanović Nikola Z., et al.
Published: (2019-01-01)

Immunolocalization of Matrix Metalloproteinases 2 and 9 and Their Inhibitors in the Hearts of Rats Treated with Immunosuppressive Drugs—An Artificial Intelligence-Based Digital Analysis
by: Aleksandra Wilk, et al.
Published: (2024-03-01)

Impact of Switching From Immediate- or Prolonged-Release to Once-Daily Extended-Release Tacrolimus (LCPT) on Tremor in Stable Kidney Transplant Recipients: The Observational ELIT Study
by: Magali Giral, et al.
Published: (2024-04-01)

Comparison of different methods to assess tacrolimus concentration intra-patient variability as potential marker of medication non-adherence
by: Barbora Kostalova, et al.
Published: (2022-10-01)

Tacrolimus for Ophthalmic Use: An Update
by: Sana Ilias Tinwala, et al.
Published: (2013-01-01)

Calcineurin–NFAT signalling in myeloid leucocytes: new prospects and pitfalls in immunosuppressive therapy
by: Kamila Bendickova, et al.
Published: (2017-06-01)

Development of a predictive nomogram for switching immunosuppressive drugs in pediatric liver transplant recipients
by: Guangxiang Gu, et al.
Published: (2023-10-01)

Rituximab, Mycophenolic Acid, and Calcineurin Inhibitors Achieve Long-Term Remission in Pediatric Focal Segmental Glomerulosclerosis with Steroid-Resistant and Frequently Relapsing Nephrotic Syndrome: A Report of Two Cases
by: Cahyani Gita Ambarsari, et al.
Published: (2022-10-01)

Effects of switching from twice-daily tacrolimus to once-daily extended-release meltdose tacrolimus on cellular immune response
by: Moritz Anft, et al.
Published: (2024-09-01)

Validation of an automated sample preparation module directly connected to LC-MS/MS (CLAM-LC-MS/MS system) and comparison with conventional immunoassays for quantitation of tacrolimus and cyclosporin A in a clinical setting
by: Tsutomu Shimada, et al.
Published: (2024-01-01)

The effect of tacrolimus conversion from immediate- to extended-release formulation on renal function in renal transplant patients: a meta-analysis
by: Sheng Chao, et al.
Published: (2023-10-01)

The Use of Tacrolimus in Ophthalmology: A Review on Chronic and Acute Management
by: Abdulrhman Mustafa Almaghrabi, et al.
Published: (2024-07-01)

Generic tacrolimus in kidney transplant patients at Jordan University hospital
by: Ayman M Wahbeh, et al.
Published: (2024-01-01)

The role of calcineurin inhibitors in the progression of hepatocellular carcinoma after liver transplantation
by: O. D. Olisov, et al.
Published: (2022-09-01)

Function of external respiration in patients after kidney transplantation under conditions of immunosuppressive therapy.
by: O. V. Kuryata, et al.
Published: (2018-04-01)

Reducing the Pill Burden: Immunosuppressant Adherence and Safety after Conversion from a Twice-Daily (IR-Tac) to a Novel Once-Daily (LCP-Tac) Tacrolimus Formulation in 161 Liver Transplant Patients
by: Max M. Maurer, et al.
Published: (2022-01-01)

A comparative analysis of drug-induced kidney injury adverse reactions between cyclosporine and tacrolimus based on the FAERS database
by: Min Xu, et al.
Published: (2025-05-01)

The Antiviral Properties of Cyclosporine. Focus on Coronavirus, Hepatitis C Virus, Influenza Virus, and Human Immunodeficiency Virus Infections
by: Paulina Glowacka, et al.
Published: (2020-07-01)

Tacrolimus-induced Ascites after Liver Transplant
by: M Hosseini, et al.
Published: (2018-04-01)

Efficacy and safety of a switch from twice-daily tacrolimus to once-daily generic tacrolimus in stable liver transplant patients
by: Jong Man Kim, et al.
Published: (2021-09-01)

Personalized dosing protocol for extended-release tacrolimus in kidney transplant recipients in the early postoperative period
by: A. V. Shabunin, et al.
Published: (2023-04-01)